Cargando…
PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes
INTRODUCTION: New ‘heated tobacco products’ are being marketed in several countries with claims that they expose users to lower levels of toxins than conventional cigarettes which could be read as being less likely to cause health problems than conventional cigarettes. In the USA, Philip Morris Inte...
Autor principal: | Glantz, Stanton A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202159/ https://www.ncbi.nlm.nih.gov/pubmed/30131374 http://dx.doi.org/10.1136/tobaccocontrol-2018-054413 |
Ejemplares similares
-
Heated tobacco products: the example of IQOS
por: Glantz, Stanton A
Publicado: (2018) -
Potential Harm of IQOS Smoke to Rat Liver
por: Granata, Silvia, et al.
Publicado: (2023) -
Perceived relative harm of heated tobacco products (IQOS), e-cigarettes, and cigarettes among adults in Canada: Findings from the ITC Project
por: Sutanto, Edward, et al.
Publicado: (2020) -
Risk perception of IQOS™ and cigarettes: Temporal and cross-country comparisons
por: AlMoosawi, Suzana, et al.
Publicado: (2022) -
Comparing the Characteristics of Cigarette Smoking and e-Cigarette and IQOS Use among Adolescents in Taiwan
por: Lee, Yue-Chune, et al.
Publicado: (2020)